Shanghai Institute of Materia Medica Chinese Academy of Sciences is a company that provides Tocilizumab, Rituximab, Toll-like receptor and more. Shanghai Institute of Materia Medica Chinese Academy of Sciences is headquartered in China . Shanghai Institute of Materia Medica Chinese Academy of Sciences has a total of 3,997 patents and 2 literature
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of Shanghai Institute of Materia Medica Chinese Academy of Sciences
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by Shanghai Institute of Materia Medica Chinese Academy of Sciences